Table 4.
Baseline ART regimens and regimen changes during study period
| Surgery date | Pre-surgery | Post-surgery #1 | Post-surgery #2 |
|---|---|---|---|
| 11/2011 | ABC/3TC/AZT, RAL | - | - |
| 11/15/11 | EFV/FTC/TDF | - | - |
| 1/16/13 | ABC/3TC, ATV/r | - | - |
| 2015 | ABC/3TC, ATV | - | - |
| 4/21/15 | FTC/TDF, FPV, RAL | - | - |
| 7/28/15 | FTC/TDF, ATV/r | - | - |
| 8/10/15* | EVG/c/FTC/TDF | - | - |
| 9/8/15 | FTC/TDF, ETR, RAL | - | - |
| 6/17/16 | ATV, ABC, DTG, 3TC | ABC, DTG, 3TC | - |
| 9/13/16 | FTC/TDF, DTG | - | - |
| 1/12/17 | ABC/3TC, DRV/c | - | - |
| 5/15/17 | FTC/TAF, DTG | - | - |
| 8/22/17 | FTC/TAF, DTG | - | - |
| 8/25/17 | FTC/TAF, DTG | - | - |
| 11/17/17 | FTC/TAF, DRV/r | FTC/TDF, DRV/r | FTC/TAF, DTG |
| 4/16/18 | ABC/DTG/3TC |
(1) FTC/TAF, DTG (2) BIC/FTC/TAF |
- |
| 6/18/18 | FTC/TAF, DRV/c | BIC/FTC/TAF | - |
| 7/25/18 | FTC/TAF, DTG | - | - |
*Patient who suffered virologic failure
Regimens only listed in post-surgery 1 and 2 columns if regimen was changed. Separate dosage forms aside from ritonavir as a pharmacokinetic booster separated by comma. Post-surgery #1 = 6 months (± 3 months), post-surgery #2 = 12 months (± 3 months).
Abbreviations: ABC abacavir, 3TC lamivudine, ATV atazanavir, EFV efavirenz, FTC emtricitabine, TDF tenofovir disoproxil fumarate, RAL raltegravir, AZT zidovudine, r ritonavir, FPV fosamprenavir, EVG elvitegravir, c cobicistat, ETR etravirine, DTG dolutegravir, TAF tenofovir alafenamide, DRV darunavir, BIC bictegravir